Advertisement

Ovarian Cancer: Surgical Considerations

  • Kara C. Long
  • Dennis S. ChiEmail author
Chapter

Abstract

Cytoreductive surgery (CRS) followed by platinum-based chemotherapy is the cornerstone of treatment for advanced epithelial ovarian cancer (EOC). While elderly patients are generally at an increased risk for perioperative morbidity, many studies demonstrate that the elderly are just as likely to benefit from aggressive standard of care treatment as are younger patients. Despite this, elderly patients with cancer are more likely to undergo substandard surgical management, resulting in poorer disease-specific and overall survival. In order to optimize the benefit of CRS while minimizing the risks of perioperative complications, patients must be carefully selected and prepared for surgery. The following chapter presents the current evidence regarding CRS in older patients and reviews important aspects of patient selection, preoperative preparation, intraoperative techniques, postoperative care, and management of complications in older patients with EOC.

Keywords

Elderly Ovarian cancer Cytoreductive surgery Perioperative care Postoperative complication 

References

  1. 1.
    Ries LAG, Harkins D, Krapcho M, Mariotto A, Miller BA, Feuer EJ, Clegg L, Eisner MP, Horner MJ, Howlader N, Hayat M, Hankey BF, Edwards BK (eds). SEER Cancer Statistics Review, 1975–2003, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975_2003 based on November 2005 SEER data submission, posted to the SEER web site, 2006.
  2. 2.
    Chi DS, Eisenhauer EL, Lang J, et al. What is the optimal goal of primary cytoreductive ­surgery for bulky stage IIIC epithelial ovarian carcinoma (EOC)? Gynecol Oncol. 2006;103(2):559–64.PubMedCrossRefGoogle Scholar
  3. 3.
    Markman M, Lewis JL, Saigo P, et al. Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience. Cancer. 1993;71(2 Suppl):634–7.PubMedGoogle Scholar
  4. 4.
    Wanebo HJ, Cole B, Chung M, et al. Is surgical management compromised in elderly patients with breast cancer? Ann Surg. 1997;225(5):579–89.PubMedCrossRefGoogle Scholar
  5. 5.
    Bugeja G, Kumar A, Banerjee AK. Exclusion of elderly people from clinical research: a descriptive study of published reports. BMJ. 1997;315(7115):1059.PubMedCrossRefGoogle Scholar
  6. 6.
    Hutchins LF, Unger JM, Crowley JJ, Coltman CA, Albain KS. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med. 1999;341(27):2061–7.PubMedCrossRefGoogle Scholar
  7. 7.
    Townsley CA, Selby R, Siu LL. Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol. 2005;23(13):3112–24.PubMedCrossRefGoogle Scholar
  8. 8.
    Harter P, Du Bois A, Schade-Brittinger C, et al. Non-enrolment of ovarian cancer patients in clinical trials: reasons and background. Ann Oncol. 2005;16(11):1801–5.PubMedCrossRefGoogle Scholar
  9. 9.
    Hightower RD, Nguyen HN, Averette HE, et al. National survey of ovarian carcinoma. IV: patterns of care and related survival for older patients. Cancer. 1994;73(2):377–83.PubMedCrossRefGoogle Scholar
  10. 10.
    Díaz-Montes TP, Zahurak ML, Giuntoli RL, et al. Surgical care of elderly women with ovarian cancer: a population-based perspective. Gynecol Oncol. 2005;99(2):352–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Eisenhauer EL, Tew WP, Levine DA, et al. Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy. Gynecol Oncol. 2007;92(1):27–34.Google Scholar
  12. 12.
    Aletti GD, Dowdy SC, Podratz KC, Cliby WA. Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system. Gynecol Oncol. 2007;105(1):84–9.PubMedCrossRefGoogle Scholar
  13. 13.
    Aletti GD, Gostout BS, Podratz KC, Cliby WA. Ovarian cancer surgical resectability: relative impact of disease, patient status, and surgeon. Gynecol Oncol. 2006;100(1):33–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Sharma S, Driscoll D, Odunsi K, Venkatadri A, Lele S. Safety and efficacy of cytoreductive surgery for epithelial ovarian cancer in elderly and high-risk surgical patients. Am J Obstet Gynecol. 2005;193(6):2077–82.PubMedCrossRefGoogle Scholar
  15. 15.
    Langstraat C, Aletti GD, Cliby WA. Morbidity, mortality and overall survival in elderly women undergoing primary surgical debulking for ovarian cancer: a delicate balance requiring ­individualization. Gynecol Oncol. 2011;123:187–91.PubMedCrossRefGoogle Scholar
  16. 16.
    Fotopoulou C, Savvatis K, Steinhagen-Thiessen E, et al. Primary radical surgery in elderly patients with epithelial ovarian cancer: analysis of surgical outcome and long-term survival. Int J Gynecol Cancer. 2010;20(1):542–51.CrossRefGoogle Scholar
  17. 17.
    Uyar D, Frasure HE, Markman M, Von Gruenigen VE. Treatment patterns by decade of life in elderly women (> or =70 years of age) with ovarian cancer. Gynecol Oncol. 2005;98(3):403–8.PubMedCrossRefGoogle Scholar
  18. 18.
    Cloven NG, Manetta A, Berman ML, Kohler MF, DiSaia PJ. Management of ovarian cancer in patients older than 80 years of age. Gynecol Oncol. 1999;73(1):137–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Moore KN, Reid MS, Fong DN, et al. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply? Gynecol Oncol. 2008;110(2):133–9.PubMedCrossRefGoogle Scholar
  20. 20.
    Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol. 2002;20(5):1248–59.PubMedCrossRefGoogle Scholar
  21. 21.
    Vergote I, Tropé CG, Amant F, et al. Neoadjuvant chemotherapy or primary surgery in advanced ovarian cancer. N Engl J Med. 2010;363(24):2371; author reply 2372.Google Scholar
  22. 22.
    Aletti GD, Eisenhauer EL, Santillan A, et al. Identification of patient groups at highest risk from traditional approach to ovarian cancer treatment. Gynecol Oncol. 2011;120(1):23–8.PubMedCrossRefGoogle Scholar
  23. 23.
    Pope D, Ramesh H, Gennari R, et al. Pre-operative assessment of cancer in the elderly (PACE): a comprehensive assessment of underlying characteristics of elderly cancer patients prior to elective surgery. Surg Oncol. 2006;15(4):189–97.PubMedCrossRefGoogle Scholar
  24. 24.
    Kehoe SM, Eisenhauer EL, Chi DS. Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomy/resection, splenectomy, and distal pancreatectomy. Gynecol Oncol. 2008;111(2 Suppl):S51–5.PubMedCrossRefGoogle Scholar
  25. 25.
    Long KC, Levinson KL, Diaz JP, et al. Ventral hernia following primary laparotomy for ovarian, fallopian tube, and primary peritoneal cancers. Gynecol Oncol. 2011;120(1):33–7.PubMedCrossRefGoogle Scholar
  26. 26.
    Millbourn D, Cengiz Y, Israelsson LA. Effect of stitch length on wound complications after closure of midline incisions: a randomized controlled trial. Arch Surg. 2009;144(11):1056–9.PubMedCrossRefGoogle Scholar
  27. 27.
    Israelsson LA, Jonsson T. Closure of midline laparotomy incisions with polydioxanone and nylon: the importance of suture technique. Br J Surg. 1994;81:1606–8.PubMedCrossRefGoogle Scholar
  28. 28.
    Turrentine FE, Wang H, Simpson VB, Jones RS. Surgical risk factors, morbidity, and mortality in elderly patients. J Am Coll Surg. 2006;203(6):865–77.PubMedCrossRefGoogle Scholar
  29. 29.
    Friedman WH, Gallup DG, Burke JJ, Meister EA, Hoskins WJ. Outcomes of octogenarians and nonagenarians in elective major gynecologic surgery. Am J Obstet Gynecol. 2006;195(2):547–52; discussion 552–3.PubMedCrossRefGoogle Scholar
  30. 30.
    Ben-Ami I, Vaknin Z, Schneider D, Halperin R. Perioperative morbidity and mortality of gynecological oncologic surgery in elderly women. Int J Gynecol Cancer. 2006;16(1):452–7.PubMedCrossRefGoogle Scholar
  31. 31.
    Díaz-Montes TP, Zahurak ML, Bristow RE. Predictors of extended intensive care unit resource utilization following surgery for ovarian cancer. Gynecol Oncol. 2007;107(3):464–8.PubMedCrossRefGoogle Scholar
  32. 32.
    Eisenhauer EL, D’Angelica MI, Abu-Rustum NR, et al. Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced mullerian cancer. Gynecol Oncol. 2006;103(3):871–7.PubMedCrossRefGoogle Scholar
  33. 33.
    Kehoe SM, Eisenhauer EL, Abu-Rustum NR, et al. Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer. Gynecol Oncol. 1989;112(3):301–6.Google Scholar

Copyright information

© Springer-Verlag London 2013

Authors and Affiliations

  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Gynecology Service, Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations